Parkinson's Life

Insight into Parkinson’s: “join us as we make history”

We talk to the founder of the ‘Insight into Parkinson’s’ summit

Parkinson’s and animal testing: the case against

In the second in our series, we explore the debate

Do we have the right to test Parkinson’s medications on animals?

We explore the debate surrounding Parkinson’s and animal testing

Brian Lowe: “Always look on the bright side of life”

The latest in our monthly series profiling WPC2019 bloggers

The future of Parkinson’s and medicinal plants

The Parkinson’s Foundation hosts leading experts

Parkinson’s in the news: February

A roundup of Parkinson’s news stories in February.

Load more recent articles

Could a transplant lower the risk of Parkinson’s?

Researchers at Washington University School of Medicine, US, have found that having a heart, kidney, lung or bone marrow transplant could reduce the risk of developing Parkinson’s. As part of the study, published in medical journal ‘Parkinsonism & Related Disorders’, the team assessed data of just under 200,000 patients – 89,790 of whom had Parkinson’s. The results revealed that individuals who had a transplant were 37% less likely to develop Parkinson’s. This could be due to the immunosuppressant medication patients receive before undergoing a transplant, which researchers believe may help slow neurodegeneration as it reduces inflammation in the brain. The study said: “This study provides evidence that tissue transplant may be associated with a lower PD [Parkinson’s disease] risk, warranting further investigation to identify factors that mediate this relationship.”

Groundbreaking Parkinson’s trial publishes results

A breakthrough Parkinson’s trial that featured in a two-part documentary on UK television channel BBC Two has published its results. The study, which featured in the documentary ‘The Parkinson’s Drug Trial: A miracle cure?’, aimed to investigate whether it was possible to restore damaged neurons by administering protein Glial Cell Line Derived Neurotrophic Factor (GDNF). As part of the trial, scientists initially infused GDNF into the brains of six participants living with the condition. Researchers then invited a further 35 individuals with Parkinson’s to take part, with approximately half being administered with a placebo infusion. Although not conclusive, the results suggest that GDNF had an impact on the brain and researchers believe the topic is worthy of further study. Dr Alan Whone, principal investigator on the trial, said: “This represents some of the most compelling evidence yet that we may have a means to possibly reawaken and restore the dopamine brain cells…

Course for Parkinson’s nurses launches in Slovenia

The International Parkinson and Movement Disorder Society is hosting its third summer school for nurses specialising in Parkinson’s. The course – which will be held from 10-12 May in Ljubljana, Slovenia – will focus on the management of the motor and non-motor symptoms of the condition. Students will also attend lectures, examine Parkinson’s patients and discuss treatment plans with experts. All lectures will be presented in English. Heather Vitale, senior programme manager at the International Parkinson and Movement Disorder Society, said: “This course offers a unique opportunity for nurses to enhance their knowledge in Parkinson’s disease, while also learning and networking with their peers through case study presentations and small group discussions.” Registration closes 26 April 2019 and costs USD $350.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

HOME

Insight into Parkinson’s: “join us as we make history”

Parkinson’s and animal testing: the case against

Parkinson’s in the news: February

Interviews

Special reports

Global update

Interviews

Insight into Parkinson’s: “join us as we make history”

Special reports

Parkinson’s and animal testing: the case against

Special reports

Do we have the right to test Parkinson’s medications on animals?

Interviews

Brian Lowe: “Always look on the bright side of life”

Global update

The future of Parkinson’s and medicinal plants

Global update

Parkinson’s in the news: February

{categories}

{title}

Could a transplant lower the risk of Parkinson’s?

Groundbreaking Parkinson’s trial publishes results

Course for Parkinson’s nurses launches in Slovenia

{title}

Subscribe

Insight into Parkinson’s: “join us as we make history”

Parkinson’s and animal testing: the case against

Parkinson’s in the news: February

Interviews

Special reports

Global update

Interviews

Insight into Parkinson’s: “join us as we make history”

Special reports

Parkinson’s and animal testing: the case against

Special reports

Do we have the right to test Parkinson’s medications on animals?

Interviews

Brian Lowe: “Always look on the bright side of life”

Global update

The future of Parkinson’s and medicinal plants

Global update

Parkinson’s in the news: February

{categories}

{title}

Could a transplant lower the risk of Parkinson’s?

Groundbreaking Parkinson’s trial publishes results

Course for Parkinson’s nurses launches in Slovenia

{title}

Subscribe

Sign in

Want the latest Parkinson’s Life news and content delivered straight to your inbox? Subscribe here!